Caribou Biosciences' Series B Round

Caribou Biosciences raised a round of funding on May 16, 2016.

Caribou Biosciences is a developer of cellular engineering and analysis solutions based on CRISPR technologies, which provide enhanced capabilities to therapeutic development, agricultural biotechnolo…

Articles about Caribou Biosciences' Series B Round: